4974 On Other Exchanges
4974 is not on other exchanges.

takara bio inc (4974) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TAKARA BIO INC (4974)

Related News

No related news articles were found.

takara bio inc (4974) Related Businessweek News

No Related Businessweek News Found

takara bio inc (4974) Details

Takara Bio Inc. operates as a biotechnology company in Japan, the United States, Asia, Europe, and internationally. It operates in three segments: Bio Industry, Gene Therapy, and AgriBio. The company develops research reagents and scientific instruments, such as restriction enzymes, PCR reagents, antibodies, cell culture media and gas-permeable bags, real-time PCR equipment, mass spectrometry systems, etc. It also provides research and contract manufacturing services comprising genome analysis, DNA chip analysis, IPS cell contract production services, cell processing and preparation, vector production, safety testing, technical support services for cancer immunotherapy, etc. In addition, the company engages in the development of various gene therapies, including HF10 anti-cancer therapy that is in Phase II clinical trials targeting malignant melanoma; siTCR gene therapy, which is in Phase I clinical trials for the treatment of esophageal cancer, synovial sarcoma, etc.; and MazF gene therapy, which is in Phase I clinical trials for patients infected with the human immunodeficiency virus. Further, it researches on functional properties derived from traditional Japanese food ingredients; and provides functional food ingredients as raw materials for foods, drinks, and cosmetics. Additionally, the company provides functional foods, such as Fucoidan from Gagome kombu, Isosamidin from herbs, Chalcone from Ashitaba, Agaro-oligosaccharide from Agar, Yamsgenin from the lesser yam, and Terpene from a mushroom. It also cultivates, produces, and markets various mushroom types, such as Honshimeji, Hatakeshimeji, and Bunashimeji, as well as licenses mushroom production technology. The company was founded in 2002 and is headquartered in Kusatsu, Japan. Takara Bio Inc. is a subsidiary of Takara Holdings Inc.

Founded in 2002

takara bio inc (4974) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

takara bio inc
Takara Bio Inc., 2017 Earnings Call, May 11, 2017

Takara Bio Inc., 2017 Earnings Call, May 11, 2017

Takara Bio Inc. to Report Fiscal Year 2017 Results on May 09, 2017

Takara Bio Inc. announced that they will report fiscal year 2017 results on May 09, 2017

Takara Bio Inc. - Special Call

Takara Bio Inc. - Special Call


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4974 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4974.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4974 Industry Range
Price/Earnings 100.0x
Price/Sales 6.1x
Price/Book 3.0x
Price/Cash Flow 133.6x
TEV/Sales 5.1x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TAKARA BIO INC, please visit www.takara-bio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.